Identification of novel biomarkers in prostate cancer diagnosis and prognosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of novel biomarkers in prostate cancer diagnosis and prognosis
Authors
Keywords
-
Journal
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-10
DOI
10.1002/jbt.23137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis
- (2021) Yan Wang et al. PLoS One
- miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9
- (2021) Lei Zhang et al. Frontiers in Oncology
- Tumor protein D52 promotes breast cancer proliferation and migration via the long non-coding RNA NEAT1/microRNA-218-5p axis
- (2021) Jing Ren et al. Annals of Translational Medicine
- Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer
- (2020) Jan K. Hennigs et al. Scientific Reports
- Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients
- (2020) Junchao Bai et al. MEDICINE
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis
- (2020) Guanghui Jia et al. ONCOLOGY REPORTS
- Thymidine kinase 1 through the ages: a comprehensive review
- (2020) Eliza E. Bitter et al. Cell and Bioscience
- Disturbed Flow Increases UBE2C (Ubiquitin E2 Ligase C) via Loss of miR-483-3p, Inducing Aortic Valve Calcification by the HIF-1α (Hypoxia-Inducible Factor-1α) Pathway in Endothelial Cells
- (2019) Joan Fernandez Esmerats et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Decreased miR-218–5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer
- (2019) Peng Peng et al. Oncology Research and Treatment
- PSA-Screening und molekulare Marker
- (2019) J. Lakes et al. UROLOGE
- A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
- (2019) Ying Z. Mazzu et al. CLINICAL CANCER RESEARCH
- Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis
- (2019) Zhen-yu Song et al. Aging-US
- Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China
- (2019) X. Liu et al. PUBLIC HEALTH
- miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database
- (2019) Hsi-Yuan Huang et al. NUCLEIC ACIDS RESEARCH
- circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6
- (2019) Weidong Wu et al. OncoTargets and Therapy
- Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence
- (2019) Qingke Chen et al. Biomed Research International
- Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C
- (2019) Jimeng Hu et al. Cancer Medicine
- Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II
- (2019) Joyce H. Lee et al. Genes
- LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
- (2019) Xingkang Jiang et al. CELLULAR SIGNALLING
- The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier
- (2018) Zhen Cao et al. BIOINFORMATICS
- Noncoding RNA:RNA Regulatory Networks in Cancer
- (2018) Jia Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy
- (2018) Junfeng Li et al. ONCOLOGY REPORTS
- Overexpression of TPX2 is associated with progression and prognosis of prostate cancer
- (2018) Jun Zou et al. Oncology Letters
- Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
- (2018) Kiran Kumar Jagarlamudi et al. Biomarkers in Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling
- (2018) Muhammad Shahid et al. CELL CYCLE
- Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1
- (2018) Guoxian Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics
- (2018) Zu‑Cheng Xie et al. Molecular Medicine Reports
- Upregulation of centromere protein F is linked to aggressive prostate cancers
- (2018) Cosima Göbel et al. Cancer Management and Research
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
- (2017) Hung-Wei Pan et al. OncoTargets and Therapy
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways
- (2017) Lei Chen et al. PLoS One
- dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers
- (2016) Zhen Yang et al. NUCLEIC ACIDS RESEARCH
- Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
- (2015) Kiran Kumar Jagarlamudi et al. BMC CANCER
- ceRNA in cancer: possible functions and clinical implications
- (2015) Xiaolong Qi et al. JOURNAL OF MEDICAL GENETICS
- DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts
- (2015) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
- (2015) Martin Mørck Mortensen et al. Scientific Reports
- cytoHubba: identifying hub objects and sub-networks from complex interactome
- (2014) Chia-Hao Chin et al. BMC Systems Biology
- Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer
- (2013) Marina França de Resende et al. Journal of Translational Medicine
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Loss of Survivin in the Prostate Epithelium Impedes Carcinogenesis in a Mouse Model of Prostate Adenocarcinoma
- (2013) Helty Adisetiyo et al. PLoS One
- The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers
- (2013) Yasheng Huang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients
- (2011) Julija Hmeljak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer
- (2009) W.R. Miller JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started